| Title |
Update on use of aldesleukin for treatment of high-risk metastatic melanoma
|
|---|---|
| Published in |
ImmunoTargets and Therapy, April 2015
|
| DOI | 10.2147/itt.s61590 |
| Pubmed ID | |
| Authors |
Rodabe N Amaria, Alexandre Reuben, Zachary A Cooper, Jennifer A Wargo |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Austria | 1 | 1% |
| Unknown | 68 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 17% |
| Student > Bachelor | 10 | 14% |
| Student > Ph. D. Student | 10 | 14% |
| Other | 7 | 10% |
| Student > Master | 7 | 10% |
| Other | 4 | 6% |
| Unknown | 19 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 16% |
| Biochemistry, Genetics and Molecular Biology | 10 | 14% |
| Agricultural and Biological Sciences | 9 | 13% |
| Immunology and Microbiology | 8 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
| Other | 6 | 9% |
| Unknown | 20 | 29% |